SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - Sophia Genetics ( NASDAQ:SOPH ) , AstraZeneca ( NASDAQ:AZN )
The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months
| Ticker |
Sentiment |
Impact |
|
AZN
|
Neutral
|
26 %
|
|
SOPH
|
Neutral
|
49 %
|
